AIDS Clinical Trial - Efficacy & Safety of GSK Biologicals HIV Vaccine in

Clinical Trial Summary

This study is designed to determine whether administration of the GSK Biologicals HIV vaccine 732462 can lead to a reduction in viral load, and impact on the course of human immunodeficiency virus type 1 (HIV-1) infection. In HIV-1 infected persons who have not yet started antiretroviral therapy (ART), such a vaccine would potentially lead to a delay in the initiation of treatment.

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06044792` - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Not yet recruiting	`NCT03661203` - Investigation of the Psychosocial Factors Responsible for the Late Recourse to HIV Testing Within MSM
Completed	`NCT02711878` - Healing Hearts and Mending Minds in Older Adults Living With HIV	N/A
Completed	`NCT02606344` - Effect of a Micro-finance-based Intervention for the Prevention of Intimate-partner Violence and HIV	N/A
Completed	`NCT01053598` - Evaluation Of The Performance Of The Nitrate Reductase And Resazurin Titre Assay For The Detection of Mycobacterium Tuberculosis Complex From Sputum In A High Tb and Hiv Setting	N/A
Completed	`NCT01348308` - Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients	Phase 3
Completed	`NCT01237366` - Study Targeting Affect Regulation	Phase 1/Phase 2
Withdrawn	`NCT00951795` - Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts	N/A
Completed	`NCT00740389` - TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.	Phase 1
Withdrawn	`NCT00347750` - Pharmacokinetics and Pharmacodynamics of an Anti-HIV Drug in Israeli Ethiopian and Non-Ethiopian Populations	Phase 3
Withdrawn	`NCT00340223` - HLA-B35 Alleles and AIDS	N/A
Completed	`NCT00317460` - Buprenorphine and Integrated HIV Care	Phase 4
Completed	`NCT01084395` - Reducing HIV Risk Among Mexican Youth	N/A
Completed	`NCT00144352` - In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Adults	Phase 4
Completed	`NCT00202241` - The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS	N/A
Completed	`NCT00341172` - The Effects of Genetic Differences Among AIDS Patients on Cytomegalovirus Retinitis
Recruiting	`NCT06145841` - Metagenomic Next-Generation Sequencing Guides Anti-Infection Strategies
Completed	`NCT03633721` - Acute Effects of Cannabis on Cognition and Mobility in Older HIV-infected and HIV-Un-infected Women	Phase 2
Completed	`NCT04567693` - Reducing Time to Spaced-out Appointments for Newly-diagnosed People Living With HIV	N/A
Completed	`NCT03023033` - Supporting Attendance for Facility Delivery and Infant Health	N/A

NCT number	NCT01218113
Study type	Interventional
Source	GlaxoSmithKline
Contact
Status	Completed
Phase	Phase 2
Start date	November 8, 2010
Completion date	November 5, 2012

Efficacy and Safety of GSK Biologicals HIV Vaccine in Antiretroviral Therapy (ART)-naïve HIV-1 Infected Persons

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms